Home > Cashflow Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Cashflow Statement

BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹4.15 Cr₹7.35 Cr₹12 Cr₹5.19 Cr₹5.83 Cr
Adjustment ₹10 Cr₹7.59 Cr₹7.88 Cr₹5.50 Cr₹3.82 Cr
Changes In working Capital ₹7.55 Cr₹-5.28 Cr₹-14 Cr₹-0.80 Cr₹-23 Cr
Cash Flow after changes in Working Capital ₹22 Cr₹9.66 Cr₹5.08 Cr₹9.90 Cr₹-14 Cr
Cash Flow from Operating Activities ₹22 Cr₹9.48 Cr₹4.95 Cr₹9.73 Cr₹-14 Cr
Cash Flow from Investing Activities ₹-21 Cr₹-15 Cr₹-7.49 Cr₹-6.54 Cr₹-5.35 Cr
Cash Flow from Financing Activities ₹1.06 Cr₹-0.85 Cr₹10 Cr₹-4.81 Cr₹12 Cr
Net Cash Inflow / Outflow ₹2.04 Cr₹-6.41 Cr₹7.64 Cr₹-1.63 Cr₹-6.68 Cr
Opening Cash & Cash Equivalents ₹1.40 Cr₹7.81 Cr₹0.17 Cr₹1.80 Cr₹8.48 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹3.43 Cr₹1.40 Cr₹7.81 Cr₹0.17 Cr₹1.80 Cr

Compare Cashflow Statement of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹314.3 Cr 17% 23.4% 68.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,050.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹158,157.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,531.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,190.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹98,892.8 Cr 2.6% -7.4% -16.3% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

17%

23.4%

68.9%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses